| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 04/10/2003 | WO2002000174A3 Compositions and methods for the therapy and diagnosis of lung cancer |
| 04/10/2003 | WO2001092547A9 Modified bovine adenovirus having altered tropism |
| 04/10/2003 | US20030069406 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of blood disorders |
| 04/10/2003 | US20030069201 Methods of using BCL-2 for the therapeutic treatment and prevention of diseases |
| 04/10/2003 | US20030069200 Use of glucosylceramide synthesis inhibitors in brain cancertherapy |
| 04/10/2003 | US20030069197 Probes and primers can be employed in diagnostic kits, in identifying or isolating mammalian PTTG nucleic acid, and in detecting a pathological mass associated with PTTG expression. |
| 04/10/2003 | US20030069195 Suppression of polymorphic alleles |
| 04/10/2003 | US20030069181 Alternative splice forms of proteins as basis for multiple therapeutic modalities |
| 04/10/2003 | US20030069173 Peptide-enhanced transfections |
| 04/10/2003 | US20030068821 Method for expression of small RNA molecules within a cell |
| 04/10/2003 | US20030068792 Therapeutic agent for use in the treatment of infections and cancer disorders |
| 04/10/2003 | US20030068691 Peptide for use in the treatment and diagnosis of nervous system, epilepsy and stroke |
| 04/10/2003 | US20030068661 Inhibition of BEHAB cleavage and primary central nervous system (CNS) tumors |
| 04/10/2003 | US20030068379 A molecular carrier containing a central multivalent core and multiple adduct molecules bonded with core, wherein adduct represents adduct moieties which can be the same of different from one another and are residues of amino acids |
| 04/10/2003 | US20030068364 Pro-liposomal encapsulated preparations (iv) |
| 04/10/2003 | US20030068333 Cocktail of >/= 4 different plasmid DNAs encoding corresponding respiratory syncytial virus antigens, coacervated with chitosan to formulate nanospheres |
| 04/10/2003 | US20030068323 Hybrid compositions for intracellular targeting |
| 04/10/2003 | US20030068307 Administering a target cell-specific adenovirus vector, comprising an adenoviral gene essential for replication under transcriptional control of a target cell-specific transcriptional regulatory element and an anticancer agent |
| 04/10/2003 | CA2776522A1 Development of a preventive vaccine for filovirus infection in primates |
| 04/10/2003 | CA2776391A1 Development of a preventive vaccine for filovirus infection in primates |
| 04/10/2003 | CA2776272A1 Development of a preventive vaccine for filovirus infection in primates |
| 04/10/2003 | CA2466020A1 Rsv gene expression vaccine |
| 04/10/2003 | CA2463404A1 Fragements of heat shock proteins and their use |
| 04/10/2003 | CA2462641A1 Whole cell engineering using real-time metabolic flux analysis |
| 04/10/2003 | CA2462632A1 Introduction of the wlds gene for prevention of axonal degeneration in neurological diseases |
| 04/10/2003 | CA2462628A1 Restricted expression lentiviral vectors |
| 04/10/2003 | CA2462602A1 Double stranded rna as an adjuvant in vaccine compositions |
| 04/10/2003 | CA2462593A1 Compositions for oral gene therapy and methods of using same |
| 04/10/2003 | CA2462424A1 A novel g protein-coupled receptor, gave 10 |
| 04/10/2003 | CA2462255A1 Method of regulating expression of gene carried on viral vector |
| 04/10/2003 | CA2462162A1 Identification of new cd8 epitopes from hiv-1 proteins with therapeuticaal and vaccinal properties against hiv infections |
| 04/10/2003 | CA2462144A1 Micro-rna molecules |
| 04/10/2003 | CA2461998A1 Isolated nucleic acid molecules encoding a bacterial uracil transport protein and a bacterial uracil phosphoribosyl-transferase enzyme, cells transformed therewith and uses thereof |
| 04/10/2003 | CA2461877A1 Method of treatment using ligand-immunogen conjugates |
| 04/10/2003 | CA2461254A1 Polypeptides derived from inducible hsp70 and pharmaceutical compositions containing the same |
| 04/10/2003 | CA2460261A1 Methods for diagnosing and treating diseases and conditions of the heart or digestive system, and cancer |
| 04/10/2003 | CA2460257A1 Methods for diagnosing and treating heart disease |
| 04/10/2003 | CA2455225A1 Novel proteins and nucleic acids encoding same |
| 04/09/2003 | EP1300468A2 TRNA synthetase |
| 04/09/2003 | EP1300419A1 Antibody of human origin for inhibiting thrombocyte aggregation |
| 04/09/2003 | EP1300161A1 Cationic lipids suitable for gene transfer |
| 04/09/2003 | EP1300158A1 Medicinal compositions for angiogenic therapy |
| 04/09/2003 | EP1299727A2 Novel tumor antigen useful in diagnosis and therapy of bladder, ovary, lung and kidney cancers |
| 04/09/2003 | EP1299562A1 Gene expression in biological conditions |
| 04/09/2003 | EP1299560A2 Identification and modulation of t helper-1 and t helper-2 cells |
| 04/09/2003 | EP1299542A2 Non-agonistic antibodies to human gp39, compositions containing, and therapeutic use thereof |
| 04/09/2003 | EP1299541A2 Method for producing and using novel human defensins as biologically active proteins for treating infections and other illnesses |
| 04/09/2003 | EP1299539A1 Myocardium-specific promoter |
| 04/09/2003 | EP1299536A1 Novel alpha-catenin expressed in heart and testis |
| 04/09/2003 | EP1299533A2 Antisense oligonucleotides to inhibit angiogenesis and/or metastasis |
| 04/09/2003 | EP1299529A2 Conserved diaphanous-related formin autoregulatory domain (dad) |
| 04/09/2003 | EP1299417A2 Compositions and methods for the therapy and diagnosis of breast cancer |
| 04/09/2003 | EP1299410A2 GFR alpha1-RET SPECIFIC AGONISTS AND METHODS THEREFOR |
| 04/09/2003 | EP1299127A2 The nip3 family of proteins |
| 04/09/2003 | EP1299126A2 Glutamic acid decarboxylase (gad) delivery system for treating neurodegenerative diseases |
| 04/09/2003 | EP1299115A2 Methods and compositions for developing spore display systems for medicinal and industrial applications |
| 04/09/2003 | EP1299087A1 Microspheres and adjuvants for dna vaccine delivery |
| 04/09/2003 | EP1299032A1 DNA encoding human serine protease D-G |
| 04/09/2003 | EP1276500A4 Blocking leukocyte emigration and inflammation by interfering with cd99/hec2 |
| 04/09/2003 | EP1230342A4 Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues |
| 04/09/2003 | EP0827396B1 Production scale method of forming microparticles |
| 04/09/2003 | EP0723455B1 Method of inhibiting phagocytosis |
| 04/09/2003 | CN1409767A Recombinant sendai virus vector for introducing exogenous gene to airway epithelia |
| 04/09/2003 | CN1409765A Prevention of myocarditis, abortion and intrauterine infection associated with procine circovirus 2 |
| 04/09/2003 | CN1409761A Method and device for treating sample and reagent |
| 04/09/2003 | CN1409722A Antagonists of BMP and TGF beta signalling pathway |
| 04/09/2003 | CN1409641A DNA- vaccine based on constructs drived from genomes of human and animal pathogens |
| 04/09/2003 | CN1408869A Mouse spermotogenous cell differentiation relative gene |
| 04/09/2003 | CN1408851A Non-coding region and P.M gene sequence and vector construction of long-47 measles virus |
| 04/09/2003 | CN1408439A Use of CC(A+T)6 GG series sequence in tumor gene radio therapy |
| 04/09/2003 | CN1408438A Gene vaccine based on macrophage colony stimulating factor recepter and its use |
| 04/09/2003 | CN1408434A Polypeptide and DNA combined vaccine for resisting animal's foot-and-mouth disease and its preparing method |
| 04/09/2003 | CN1408349A Foot-and-mouth disease gene engineering polypeptide vaccine and its preparing method |
| 04/08/2003 | US6545169 Anticancer, antiprotozoa agents |
| 04/08/2003 | US6545139 Genetic engineering; anticancer agents |
| 04/08/2003 | US6545137 Autoimmune diseases; antiinflammatory agents; viricides; antidiabetic agents; binding to low density lipoproteins |
| 04/08/2003 | US6545097 Biocompatible block copolymer comprising one or more elastomeric blocks and one or more thermoplastic blocks connected by a seed polymer |
| 04/08/2003 | US6544955 Method of sensitizing tumor cells with adenovirus E1A |
| 04/08/2003 | US6544948 ΔP62, variants thereof, amino acid sequences coding therefor and their uses in gene therapy for cancer |
| 04/08/2003 | US6544786 Method and vector for producing and transferring trans-spliced peptides |
| 04/08/2003 | US6544785 Helper viruses; genetic engineering |
| 04/08/2003 | US6544784 Multiple-tumor aberrant growth genes |
| 04/08/2003 | US6544781 Gene therapy |
| 04/08/2003 | US6544779 Pseudo-type retroviral vectors with modifiable surface capsid proteins |
| 04/08/2003 | US6544771 Retroviral gene therapy vectors and therapeutic methods based thereon |
| 04/08/2003 | US6544769 Compostions comprising viruses and methods for concentrating virus preparations |
| 04/08/2003 | US6544761 Nucleotide sequences coding polypeptide for use in treatment of restenosis, arthritis and cancer |
| 04/08/2003 | US6544759 Polynucleotides encoding a novel growth factor which acts through ErbB-4 kinase receptor tyrosine |
| 04/08/2003 | US6544758 Methods for expressing endostatin protein |
| 04/08/2003 | US6544740 Measuring protease; calibration; insertion of enbryos |
| 04/08/2003 | US6544737 Genomic sequence of the purH gene and purH-related biallelic markers |
| 04/08/2003 | US6544528 For protecting cats from infection by a broad range of feline leukemia virus |
| 04/08/2003 | US6544527 Non-infectious, immunogenic, human immunodeficiency virus-like particles devoid of long terminal repeats and a functional pol coding region |
| 04/08/2003 | US6544522 Fusion proteins of mycobacterium tuberculosis antigens and their uses |
| 04/08/2003 | US6544507 Anti-neoplastic viral agents |
| 04/08/2003 | CA2184584C Vascular endothelial growth factor 2 |
| 04/04/2003 | WO2002029063A1 Novel recombinant feline herpesvirus 1 and polyvalent vaccine with the use of the same |
| 04/04/2003 | CA2424877A1 Novel recombinant feline herpesvirus 1 and polyvalent vaccine with the use of the same |
| 04/04/2003 | CA2406610A1 Embryonic stem cells and neural progenitor cells derived therefrom |
| 04/03/2003 | WO2003027927A1 Dna providing system |